Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Schoemaker

Showing results (331-340 of 360) with videos related to

Pageof 36
Sort By:
Breast Cancer Research : BCR|January 5, 2022
Common variants in breast cancer risk loci predispose to distinct tumor subtypesThomas U Ahearn, Haoyu Zhang, Kyriaki Michailidou, et al.
Nature Communications|April 1, 2026
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinomaTibor A Zwimpfer, Sian Fereday, Ahwan Pandey, et al.
British Journal of Cancer|January 26, 2021
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancersNichola Johnson, Sarah Maguire, Anna Morra, et al.
Cancer Research|February 15, 2012
19p13.1 is a triple-negative-specific breast cancer susceptibility locusKristen N Stevens, Zachary Fredericksen, Celine M Vachon, et al.
Cancer|December 27, 2022
CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium studyEun-Young Kang, Ashley Weir, Nicola S Meagher, et al.
Medrxiv : the Preprint Server for Health Sciences|October 3, 2025
Beyond <i>BRCA</i> deficiency: Clinical and molecular predictors of survival in patients with <i>BRCA</i>-deficient tubo-ovarian high-grade serous carcinomaTibor A Zwimpfer, Sian Fereday, Ahwan Pandey, et al.
Scientific Reports|August 31, 2019
Two truncating variants in FANCC and breast cancer riskThilo Dörk, Paolo Peterlongo, Arto Mannermaa, et al.
American Journal of Human Genetics|June 19, 2021
Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer elementJoseph S Baxter, Nichola Johnson, Katarzyna Tomczyk, et al.
Breast Cancer Research : BCR|June 3, 2014
Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control studyNichola Johnson, Frank Dudbridge, Nick Orr, et al.
American Journal of Human Genetics|December 3, 2013
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1Kerstin B Meyer, Martin O'Reilly, Kyriaki Michailidou, et al.
Pageof 36

Showing results (331-340 of 360) with videos related to

Sort By:
Pageof 36
Breast Cancer Research : BCR|January 5, 2022
Common variants in breast cancer risk loci predispose to distinct tumor subtypesThomas U Ahearn, Haoyu Zhang, Kyriaki Michailidou, et al.
Nature Communications|April 1, 2026
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinomaTibor A Zwimpfer, Sian Fereday, Ahwan Pandey, et al.
British Journal of Cancer|January 26, 2021
CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancersNichola Johnson, Sarah Maguire, Anna Morra, et al.
Cancer Research|February 15, 2012
19p13.1 is a triple-negative-specific breast cancer susceptibility locusKristen N Stevens, Zachary Fredericksen, Celine M Vachon, et al.
Cancer|December 27, 2022
CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium studyEun-Young Kang, Ashley Weir, Nicola S Meagher, et al.
Medrxiv : the Preprint Server for Health Sciences|October 3, 2025
Beyond <i>BRCA</i> deficiency: Clinical and molecular predictors of survival in patients with <i>BRCA</i>-deficient tubo-ovarian high-grade serous carcinomaTibor A Zwimpfer, Sian Fereday, Ahwan Pandey, et al.
Scientific Reports|August 31, 2019
Two truncating variants in FANCC and breast cancer riskThilo Dörk, Paolo Peterlongo, Arto Mannermaa, et al.
American Journal of Human Genetics|June 19, 2021
Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer elementJoseph S Baxter, Nichola Johnson, Katarzyna Tomczyk, et al.
Breast Cancer Research : BCR|June 3, 2014
Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control studyNichola Johnson, Frank Dudbridge, Nick Orr, et al.
American Journal of Human Genetics|December 3, 2013
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1Kerstin B Meyer, Martin O'Reilly, Kyriaki Michailidou, et al.
Pageof 36